Author: medicalwasted


Gammalon review

Gammalon is a drug that is used as a nootropic agent. It is produced in Japan and the quality of the drug is on the high level. The Japanese are always responsible for their products, so Gammalon can be an excellent option for the treatment of certain diseases. In this article we would like to […]


How to make money on poker in online casinos

In online casino, players can choose from several different poker game options. When these entertainments appeared on the net, there was more attention to them. Making money at poker in a casino has also become easier, but some nuances have emerged that should be considered. Poker is a popular card game that is based on […]


BMC Medicine at Digestive Disease Week 2019

BMC Medicine attended DDW 2019, one of the largest worldwide gatherings for gastroenterologists and hepatologists. Here we share some of the highlights presented during the sessions. Alessandro Recchioni Gut microbiota and the brain In a Saturday morning session, Premysl Bercik from McMaster university highlighted the interplay between the intestinal microbiota and the brain, with data coming primarily from mouse […]


The “No jab, no school” policy and vaccination efforts needed for measles elimination

Italy and France have both introduced compulsory vaccination against measles for children starting school; could similar policies be effective in stemming the alarming resurgence of measles in other high-income countries? Authors of a recent article in BMC Medicine explore this issue and the challenges in achieving measles elimination. Filippo Trentini, Piero Poletti, Alessia Melegaro & Stefano Merler, Ms 28 […]


10 sports betting rules

Sports betting is now extremely popular. Let’s try to highlight a few basic rules that will help you to earn. 1. Why make bets? You can consider betting as a business or entertainment, respectively, the approach is different. In the first case, the main thing to understand is that there is never a 100% guarantee […]


What can a patient registry tell us about the course of idiopathic pulmonary fibrosis?

Research published today in Respiratory Research presents findings from the IPF-PRO Registry, a nationwide US registry collecting data on the clinical course of Idiopathic pulmonary fibrosis (IPF) and its impact on patients. Courtesy of Dr. Laurie Snyder Idiopathic pulmonary fibrosis, or IPF, is a rare, debilitating lung disease that mainly affects individuals over the age of 60. […]